Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClean Power Hyd Regulatory News (CPH2)

Share Price Information for Clean Power Hyd (CPH2)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.25
Bid: 12.00
Ask: 12.50
Change: 0.00 (0.00%)
Spread: 0.50 (4.167%)
Open: 12.25
High: 12.25
Low: 12.25
Prev. Close: 12.25
CPH2 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Company Update

2 Nov 2023 07:00

RNS Number : 1169S
Clean Power Hydrogen
02 November 2023
 

 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

2 November 2023

Clean Power Hydrogen plc

("CPH2", the "Company" or the "Group)

Company Update

Clean Power Hydrogen plc (AIM: CPH2), the UK-based green hydrogen technology and manufacturing group that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), is pleased to announce that following an extensive testing and commissioning process it has run the entire MFE110 system, successfully producing separated hydrogen and oxygen gases at its expected capacity, witnessed by a third party customer. The creation of separated gases marks a key milestone for the Company, proving the differentiated technology works at scale. The MFE110 contains four 125KW stacks, the same sized stacks which will be used for the MFE220.

At the same time, following data accumulated during the testing, the Company announces that it has subsequently paused the MFE110 unit Factory Acceptance Test ("FAT") whilst the team re-evaluates the MFE's power down procedures making any modifications necessary to support improved plant shut down. Final tests will commence following the re-evaluation and control rectification, and upon successful completion, the MFE110 will be shipped to Northern Ireland Water's site where it will undergo site validation, integration and commissioning before beginning commercial production of hydrogen and medical grade oxygen.

The Company expects the pipeline and order book to increase significantly following the successful commercialisation and the successful milestone marks an important step in the further scaling up of CPH2's differentiated technology as it looks to roll out the MFE220.

Jon Duffy, CEO of Clean Power Hydrogen commented:

"Today marks a first very important step for CPH2 - we are now demonstrably capable of successfully producing separated hydrogen and oxygen gases at scale utilising the Company's differentiated technology. We are constantly evolving and improving our technology and look forward to finalising the Factory Acceptance Testing of the MFE110 in collaboration with our customer, which will mark the commercialisation of our ground-breaking hydrogen technology. We look forward to updating shareholders in due course following the completion of the FAT testing and delivery to Northern Ireland Water."

 Alistair Jinks of NI Water commented:

"NI Water continues to believe in the potential of CPH2's innovative electrolyser technology and recognise that significant steps have been taken in proving its capability by running the entire system and producing separated hydrogen and oxygen. The opportunity to harness oxygen in treating waste water to optimise existing assets remains a valuable prize not only for NI Water but for the global water industry which must address its harmful climate emissions. At the same time, it remains a priority to demonstrate the potential to produce affordable green hydrogen to evidence its relevance in the next phase of extending renewable electricity generation on the island of Ireland as well as its role in decarbonising transport where battery technology is not a solution. It is NI Water's assessment that whilst challenges remain in proving the logic controls and shutdown procedures, CPH2 will address these in time to ensure delivery to Belfast in early 2024."

 

ENDS

 

For more information, please contact:

 

Clean Power Hydrogen plc

via Camarco

Jon Duffy, Chief Executive Officer

James Hobson, Chief Financial Officer

Cavendish Securities plc - NOMAD & Broker

Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Adam Rae

+44 (0)131 220 9778

Camarco PR

+ 44(0) 20 3757 4980

Billy Clegg

Owen Roberts

Lily Pettifar

 

To find out more, please visit: https://www.cph2.com

 

Overview of CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited ("Clean Power") which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. The Group's MFE technology is already commercially available and demonstrating cost efficiencies and technological advantages. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFFFELLSLLIIV
12
Date   Source Headline
19th Apr 20247:00 amRNS2023 Full Year Results
23rd Feb 20247:00 amRNSAwards under Long-Term Incentive Plan
21st Feb 20247:00 amRNSOperational Update
5th Feb 20247:00 amRNSISO Certifications
28th Nov 20237:00 amRNSRevised Agreement with ATOME Energy
20th Nov 20237:00 amRNSChange of Nominated Adviser
2nd Nov 20237:00 amRNSCompany Update
21st Sep 20237:00 amRNSInterim Results
22nd Jun 20237:00 amRNS2023 Save As You Earn Scheme
21st Jun 20231:09 pmRNSResult of AGM
19th Jun 20237:00 amRNSGrant of EMI Options
6th Jun 20237:00 amRNSUpdate on Licence Agreement with GHFG Limited
17th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
28th Apr 202312:16 pmRNSHoldings in Company
26th Apr 20233:26 pmRNSPDMR Dealing
25th Apr 20237:00 amRNSCorporate Presentation
20th Apr 20237:00 amRNSMaiden Financial Results
13th Apr 20237:00 amRNSInvestor Presentation
27th Mar 20237:00 amRNSFabrum Solutions Ltd receives order from Obayashi
16th Mar 20237:00 amRNSPDMR Dealing
27th Feb 20237:00 amRNSLock-in Agreement Extension
8th Feb 20237:00 amRNSSave As You Earn Scheme
31st Jan 20237:00 amRNSManufacturing Agreement with Fabrum Solutions Ltd
26th Jan 20237:00 amRNSAppointment of Chief Technical Officer
22nd Dec 20227:00 amRNSAgreements Signed with Fabrum Solutions Ltd
20th Dec 20221:14 pmRNSHolding(s) in Company
12th Dec 20225:14 pmRNSInvestment in ATOME Energy plc
6th Dec 20227:00 amRNSSenior Management Team Strengthened
22nd Nov 202211:06 amRNSSecond Price Monitoring Extn
22nd Nov 202211:00 amRNSPrice Monitoring Extension
22nd Nov 20229:00 amRNSPrice Monitoring Extension
22nd Nov 20227:00 amRNSOperational Update
4th Oct 20224:41 pmRNSSecond Price Monitoring Extn
4th Oct 20224:35 pmRNSPrice Monitoring Extension
23rd Sep 20227:00 amRNSInterim results
23rd Sep 20227:00 amRNSInterim results
7th Sep 20224:45 pmRNSHolding(s) in Company
5th Sep 20227:00 amRNSAppointment of James Hobson as CFO
5th Sep 20227:00 amRNSAgreement with KCA Deutag Group
24th Aug 20228:11 amRNSOperational Update
19th Jul 20225:55 pmRNSResult of AGM
19th Jul 20227:45 amRNSLicence Agreement with GHFG Ltd.
23rd Jun 20225:24 pmRNSNotice of 2022 Annual General Meeting
27th May 20227:00 amRNSGroup Annual Report and Financial Statements
29th Apr 202210:16 amRNSOperations Update
4th Apr 202212:15 pmRNSAdditional purchase order from existing customer
21st Mar 20227:00 amRNSNew purchase order from additional customer
21st Mar 20227:00 amRNSOperations Update
2nd Mar 20225:31 pmRNSHolding(s) in Company
1st Mar 20224:41 pmRNSSecond Price Monitoring Extn
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.